Colloid versus crystalloid soaked gelfoam with morphine for postoperative pain relief after lumbar laminectomy  by Hassanein, Ahmed et al.
Egyptian Journal of Anaesthesia (2016) 32, 495–502HO ST E D  BY
Egyptian Society of Anesthesiologists
Egyptian Journal of Anaesthesia
www.elsevier.com/locate/egja
www.sciencedirect.comResearch ArticleColloid versus crystalloid soaked gelfoam with
morphine for postoperative pain relief after lumbar
laminectomy* Corresponding author. Tel.: +20 2862321833.
E-mail address: ahmedhassanein10@yahoo.com (A. Hassanein).
Peer review under responsibility of Egyptian Society of Anesthesiol-
ogists.
http://dx.doi.org/10.1016/j.egja.2016.08.019
1110-1849  2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Ahmed Hassanein *, Nagi S. Ali, Ahmed SaadDepartment of Anesthesiology, Minia University, Minia, EgyptReceived 24 April 2016; revised 13 August 2016; accepted 22 August 2016
Available online 5 October 2016KEYWORDS
Epidural morphine;
Gelfoam soaked in mor-
phine;
Lumbar laminectomyAbstract Background: Epidural opiate analgesia carried by gelfoam in the epidural space is to
improve the quality of perioperative pain relief. The aim of this study was to compare the analgesic
efficacy of gelfoam soaked in morphine with crystalloids versus colloid versus direct application of
morphine in epidural space in patients undergoing lumbar laminectomy under general anesthesia.
Methods: This study was a prospective, randomized, double-blinded trial. 75 male and female
patients aged from 18 to 65 years from ASA class I or II scheduled for Lumbar laminectomy sur-
gery were randomly divided into three equal groups: group A: (control group): 5 ml of 1 mg/ml
morphine was directly instilled over intact epidural space, group B (crystalloid group): apiece of gel-
foam 5 cm  1 cm soaked in 5 mg morphine diluted with 5 ml crystalloid (0.9% sodium chloride)
placed in intact epidural space; and group C (colloid group): apiece of gelfoam 5 cm  1 cm soaked
in 5 mg morphine diluted with 5 ml hydroxyethyl starch 6% (HES 6%) placed in intact epidural
space by the neurosurgeon. Total analgesics, time to first analgesic request, visual analogue scale
(VAS), hemodynamics, respiratory rates and adverse effects were recorded.
Results: As regards Patient’s characteristics, age, gender, weight, ASA class and operative time
were comparable in all studied groups, and groupsB and C showed less amount of analgesia, long
time to analgesic request, and less main VAS. No statistically significant differences are in hemody-
namics, and the incidences of side effects showed no statistically significant differences among the
three groups of study.
Conclusion: Epidural use of gelfoam soaked by morphine in HES 6% is an effective method for
post operative analgesia after lumbar laminectomy.
 2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Parenteral opioids have been the mainstay for treatment of
postoperative pain after lumbar laminectomy. The main draw-
back of parenteral opioids is that these drugs are usually given
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ations in clinical effect. Ideal postoperative analgesia should
provide continuous pain relief, in an alert patient who can
be mobilized early [1] alternatives to standard pain manage-
ment include, epidural administration of narcotics as a single
dose at the time of the surgery or via an epidural catheter post-
operatively [2]. Epidural catheters are difficult to manage and
maintain after spine surgery. In addition, there is always a con-
cern of infection, restricting its widespread application [3]. The
easy access to epidural space during laminectomy surgery was
utilized safely for applying morphine directly over the exposed
dura mater in earlier studies but has limited application due to
short duration of action (3–24 h) [4]. The routine use of surgi-
cal gelfoam in the epidural space at the completion of surgery
prompted the use of gelfoam as an extended release drug deliv-
ery system to prolong the effect of epidural morphine [5]. Ear-
lier studies have compared application of gelfoam soaked in
saline with morphine in epidural space to directly applicated
morphine [6], but no definitive conclusions can show the differ-
ences between each of colloids and crystalloids with gelfoam
soaked morphine compared to direct morphine application
and for this the present study was designed. Many studies
applied colloid in the epidural space either for management
of post spinal headache or as epidural volume expansion to
augment intrathecal block, and the study by Amira et al. [21]
was designed to examine the effects of colloid (6% HES) ver-
sus normal saline (0.9%) for epidural volume expansion in
combined spinal epidural anesthesia for elective cesarean deliv-
ery and to assess the quality of block and hemodynamic stabil-
ity. Also, several studies recommend dextran 40 colloid as an
infusion or as a bolus in the epidural space in the management
of post dural puncture headache, and conclude that the high
molecular weight and viscosity of Dextran 40 slow its removal
from the epidural space [22].
The aim of this study was to compare the analgesic efficacy
of gelfoam soaked in morphine with crystalloids versus colloid
versus direct application of morphine in epidural space in
patients undergoing lumbar laminectomy under general
anesthesia.
2. Patients and methods
This study was approved by institutional ethics committee of
El-Minia University Hospital, and carried out in duration
from March to December 2015. A written consent was
obtained from 75 male and female patients aged from 18 to
65 years from ASA class I or II undergoing lumbar laminec-
tomy. The patients were randomly allocated into three equal
groups using a computer-generated sequence of random num-
bers and a sealed envelope technique. Study drugs were pre-
pared by an anesthetist who did not participate in the
operation; this study was conducted in a random double-
blind manner (neither the administrator of the drug nor the
patient knows the nature of drugs given). We exclude with sep-
sis or coagulopathy, patients undergoing cervical laminec-
tomy, spine-fixation surgery, patient with herniated
sequestered disk, previous history of spine surgery, patients
having significant medical diseases especially neuromuscular
disease or psychological disease and sever bronchial asthma,
history of drug abuse and accidental dural tear during surgery.
Preoperative assessment and preparation: A careful medicalhistory was taken, general examination including pulse, arte-
rial blood pressure and respiratory rate, local examination
including chest, heart, and abdomen. Routine investigations
including hemoglobin concentration, coagulation profile, renal
function test, liver function test, random blood sugar and elec-
trocardiogram (ECG). Technique of the study of Standard
monitoring (i.e. electrocardiogram with two derivations, pulse
oximetry (SpO2), non-invasive arterial pressure measurement,
end tidal CO2(EtCO2), body temperature) was employed, and
baseline parameters were recorded. This monitoring was done
using Datex-Ohmeda (made by GE Healthcare Co., USA)
continued till extubation. Then 20F I.V catheter was inserted
for administration of drugs and fluids and all patients received
fluid preload (ringer’s lactate solution or isotonic saline 10 ml/
kg) and antibiotic. All patients were premedicated with 3 mg
midazolam, 50 mg ranitidine and 10 mg metoclopramide
before induction of anesthesia. Induction of anesthesia was
done for all patients with fentanyl (1 lg/kg), propofol (2 mg/
kg) and atracurium (0.5 mg/kg) followed by insertion of endo-
tracheal tube. Anesthesia was maintained by isoflurane (1.2
MAC), atracurium (0.15 mg/kg intermittent every 20–30 min)
and propofol infusion if needed to keep mean arterial blood
pressure between 60 and 65 mmHg and ventilation was
adjusted to maintain end tidal CO2 between 30 and 35. Our
work was started after the end of laminectomy stage and after
making sure that there was no accidental Dural injury before
final closure and the patient not operated for spinal fixation,
and patients were divided randomly into 3 equal groups by
computer generated randomization: Group A (control group):
5 ml of 1 mg/ml preservative-free morphine sulfate (astra-
morph, FRESENIUS KABI, USA) was directly instilled over
intact epidural space by the neurosurgeon; Group B (crystal-
loid group): apiece of gelfoam 5 cm  1 cm soaked in 5 mg
morphine diluted with 5 ml crystalloid (e.g. saline) placed in
intact epidural space by the neurosurgeon; and Group C (col-
loid group): apiece of gelfoam 5 cm  1 cm soaked in 5 mg
morphine diluted with 5 ml colloid (hydroxyethyl starch 6%)
placed in intact epidural space by the neurosurgeon. After sur-
gery was over, patients turned supine, isoflurane stopped and
neuromuscular blockade was reversed by I.V Neostigmine
(0.05 mg/kg) with 1 mg atropine, after return of spontaneous
respiration, trachea extubated and patients remain under con-
tinuous monitoring. All patients received supplemental oxygen
for the first 30 min. After this time, oxygen was administered
only when patient had saturation below 92%.
2.1. Parameters assessed
Hemodynamic parameters (heart rate, blood pressure), oxygen
saturation (SPO2), respiratory rate, VAS (visual analogue
scale: subjective pain was measured by VAS on a scale of 0–
10 with 0 representing no pain and 10 worst imaginable pains
[5]. At first 48 h postoperative opioids and other analgesic were
prohibited except if subjective pain measured by VAS was
more than 3 diclofenac sodium 75 mg ampule infused, and
the time to first analgesic request was recorded as the time
from the end of operation till the time to first analgesic request
- total analgesic consumptions in the initial 24–48 h post oper-
ative. Sedation score: Level of sedation was assessed by 5-point
ordinal scale [7], where, 0 means alert patient, 1 stands
for patient who is drowsy, 2 is for frequently drowsy and
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and difficult to arouse. Time of ambulation: patients were
encouraged to ambulate 6 h after surgery if they felt comfort-
able, and it was counted from the time at which patients were
discharged from operative room until the time that the patients
could be ambulated and it was recorded in all cases - postop-
erative complications or adverse effects such as respiratory
depression, nausea, vomiting, pruritus, bradycardia, pressure
symptoms and need for supplemental oxygen. For the purpose
of study, bradycardia was defined as heart rate less than 50
beats per minute. Respiratory depression was defined as respi-
ratory rate less than 10 per minute, need of oxygen supplemen-
tation was recorded if patients had oxygen saturation of less
than 92%, and urinary retention was labeled as absence of
spontaneous voiding more than 7 h after removal of bladder
catheter [8]. Severity of pruritus was graded as follows:
0 = absent; 1 = mild – restricted to one area not troubling
the patient and reported only on prompting the patient;
2 =Moderate – affecting a large area, not disturbing the
patient and not requiring treatment; and 3 = Severe – general-
ized, often disturbing the patient and requiring treatment [9].
All parameters were assessed hourly in the first 6 h postopera-
tive then every 2 h in the next 12 h and 4 h interval in the
remaining period of follow-up time.
Flowchart for patient allocation in the study2.2. Statistical analysis
Based on prior study, the sample size was calculated to detect
20 h difference in the time to first analgesia between study andcontrol groups at power of 0.80, confidence interval of 95%
and significance level of 0.05. Calculating for a 20% dropout
rate, 25 patients in each group were appropriate to detect this
difference. Data were analyzed using Statistical Package of
Social Sciences (SPSS) software and expressed as mean
± standard deviation and median (minimum-maximum) for
numerical data or as number and percent (%) for categorical
data. Intergroup comparisons of continuous numerical vari-
ables were done using ANOVA test for parametric data or
Kruskal-Wallis one way test for non-parametric data. Intra-
group comparisons to baseline values were done using paired
t-test for parametric data or Wilcoxon test for non-
parametric data. The level of significance was fixed at a mini-
mum of 0.05%.
3. Results
We started laminectomy by 78 patients, and we excluded 3
patients before administration of study drugs (2 cases of dural
tears and one case the surgeon decided to fix his spine), so, our
study included 75 patients, 25 in each group, who were sched-
uled for laminectomy surgery). All allocated patients com-
pleted the study. As regards Patient’s characteristics, age,
gender, weight, ASA class and operative time were comparablein all studied groups. Regarding the changes in HR in group A
baseline value was 87.64 ± 8.77 beat/min, and this value was
significant reduced at 2, 4 and 6 h postoperative while there
was significant increase in mean values at 38 and at 48 h
Table 1 Comparison of respiratory rate (RR) (breath/min).
Time Group A (n= 25) Group B (n= 25) Group C (n= 25) P-value
Baseline 13.20 ± 0.86 13.64 ± 1.43 13.60 ± 1.22 P1:0.20
13(10–14) 14(10–18) 13(12–18) P2:0.38
P3:0.69
T 2 h 11.04 ± 0.78 11.56 ± 1.41 11.04 ± 0.88 P1:0.23
11(10–13)# 11(10–15)# 11(10–14)# P2:0.85
P3:0.19
T 4 h 10.96 ± 1.05 11.80 ± 1.22 11 ± 0.91 P1:0.01*
11(10–13)# 12(10–14)# 11(10–14)# P2:0.68
P3:0.01*
T 6 h 11.36 ± 1.22 12 ± 1.41 11.80 ± 1.41 P1:0.11
11(10–14)# 12(10–15)# 11(10–15)# P2:0.30
P3:0.52
T 10 h 13.68 ± 0.98 12.92 ± 1.18 11.92 ± 1.03 P1:0.01*
14(11–15) 13(11–15)# 12(10–14)# P2:0.0001*
P3:0.004*
T 14 h 14.80 ± 1.35 12.40 ± 1.44 12.40 ± 1 P1:0.0001*
15(13–17)# 12(10–15)# 12(11–14)# P2:0.0001*
P3:0.96
T 18 h 14.44 ± 1.50 12.80 ± 1.35 12.76 ± 1.61 P1:0.001*
14(12–17)# 12(11–15)# 13(11–19)# P2:0.0001*
P3:0.79
T 22 h 13.56 ± 1.22 13.08 ± 1.03 12.32 ± 0.94 P1:0.10
13(11–17) 13(12–16) 12(10–14)# P2:0.0001*
P3:0.01*
T 30 h 14.36 ± 1.60 13.40 ± 1.38 12.60 ± 0.81 P1:0.03*
14(11–18)# 13(11–16) 12(11–14)# P2:0.0001*
P3:0.02*
T 38 h 14.60 ± 1.29 13.84 ± 2.09 13.28 ± 1.36 P1:0.33
15(12–17)# 15(10–17) 13(11–16) P2:0.002*
P3:0.21
T 48 h 14.36 ± 1.07 14.64 ± 1.46 14.72 ± 1.51 P1:0.73
14(12–17)# 14(12–18)# 15(12–17)# P2:0.19
P3:0.49
Data are expressed as mean ± standard deviation and median (minimum-maximum). P1: group A versus group B. P2: group A versus group C.
P3: group B versus group C.
* Significant inter-groups difference.
# Significant intra-group difference to baseline value.
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and this value was significantly reduced at 2, 4, 6 and 10 h
postoperative, while in group C baseline value was 8652
± 12.22 and this value was significantly reduced throughout
the study period at 2, 4, 6, 10, 14, 18, and 22. Between group
comparisons P1 (p value of comparison between A and B)
baseline values were comparable up to 6 h post operative (P1
was >0.05) but there were significant reductions in meanFigure 1 Mean of VAS in the studied groups.values of group B in comparison with group A from 10 to
48 h postoperative; P2 (P value of comparison between A
and C) baseline values were comparable up to 4 h
(P2 > 0.05) but there were significant reductions in values of
group C from 6 to 48 h postoperative; and P3 (P value of com-
parison between B and C) baseline values were comparable
between group B and C throughout the study period. Regard-
ing the changes in MAP, in group A, baseline value was 90.84
± 10.29, and all values reported throughout the study period
were comparable to the baseline values; there were significant
reductions in mean values at 2 and 4 h postoperative while it
was significantly increased at 38 and 48 h postoperative. In
group B baseline value was 93.16 ± 10.12 and all recorded val-
ues were significantly lower than baseline throughout all the
study period postoperative; in group C baseline value was
94.28 ± 8.88 and there were significant reductions in mean
values from 2 h up to 30 h. Between group comparisons, in
group B, (MAP) were significantly lower than in group A from
2 to 48 h, and in group C there were significant reductions in
values of group C from 2 h up to 38 h when compared to
group A. Regarding respiratory rate, mean changes of respira-
tory rate RR are expressed in Table 1; in group A there were
significant reductions of mean values up to 6 h postoperative,








Time to ambulation (h) 6.88 ± 1.05 6.20 ± 1.29 6 ± 1.25 P1:0.12
7(5–9) 6(4–10) 6(4–8) P2:0.03*
P3:0.82
Time to first analgesic requirement (h) 11.88 ± 1.33 38.04 ± 2.05 43.04 ± 2.13 P1:0.0001*
12(10–15) 38(34–42) 43(39–46) P2:0.0001*
P3:0.0001*
Total postoperative analgesic consumption (mg) using diclofenac sodium
amp. 75 mg
192 ± 48.7 57 ± 39.2 48 ± 36.7 P1:0.0001*
150(150–300) 75(0–150) 75(0–75) P2:0.0001*
P3:0.40
Time to discharge (days) 2.20 ± 0.40 2.44 ± 0.76 2.24 ± 0.52 P1:0.32
2(2–3) 2(2–4) 2(2–4) P2:0.96
P3:0.45
Data are expressed as mean ± standard deviation and median (minimum-maximum). P1: group A versus group B. P2: group A versus group C.
P3: group B versus group C.
#Significant intra-group difference to baseline value.
* Significant inter-groups difference.
Table 3 The incidences for different complications.
Complications Group A (n= 25) Group B (n= 25) Group C (n= 25) P-value
PONV Nausea only 8 4 4 0.28
32.0% 16.0% 16.0%
Vomiting 3 2 2 0.58
12.0% 8.0% 8.0%
Itching Mild 9 7 6 0.63
36.0% 28.0% 24.0%
Moderate 1 0 0 0.36
4.0% 0% 0%
Urinary dysfunction Urine retention 7 6 4 0.58
28.0% 24.0% 16.0%
Data are expressed as number and percent (%). Chi-square was used for inter-group comparison. PONV: postoperative nausea and vomiting.
Colloid versus crystalloid soaked gelfoam 499in group B were significantly reductions up to 18 h while in
group C there were significantly reductions up to 30 h
postoperative.
3.1. Visual analogue scale
Mean changes in visual analogue scale (VAS) are represented
in Fig. 1. VAS score was higher in group A than in group B
and C at most time points of the study, and in comparison
between B and C mean VAS score was significantly lower in
group C from 6 h till the end of study period (48 h).
The sedation scores were comparable in the 3 groups at all
set time points and there were insignificant differences in their
values throughout the studied times in the 3 groups except at
4 h and 6 h in which sedation score values were significantly
higher in group B than in the 2 other groups.
Table 2 shows time to ambulation (hours) in group C was
(6 ± 1.25) significantly earlier than in group A, and time to
first analgesic request (hours) showed that group C has
43.04 ± 2.13 which was significantly longer than both other
groups A and B have, i.e. 11.88 ± 1.33 and 38.04 ± 2.05respectively. Patients in group A significantly required higher
doses of analgesia during first 48 h postoperative (192
± 48.7 mg). When compared to group B (57 ± 39.2 mg) P1
was 0.0001 and also when compared to group C (48
± 36.7 mg) P2 was 0.0001, but there were insignificant differ-
ences when we compare group B to group C (P3 was 0.40).
There were insignificant differences in time to discharge
between the studied groups.
3.2. Side effects (Table 3)
As regards postoperative nausea and vomiting (PONV), 8
patients (32%) in group A developed postoperative nausea
only versus 4 patients (16%) in each other group and P-
value was 0.28 whereas 3 patients (12%) in group A were
observed to have vomiting versus 2 patients (8%) in each other
group and P-value was 0.58. Only one patient in each group
develops repeated vomiting and was treated by I.V ondanse-
tron 100 lg/kg. Ten patients in group A developed itching ver-
sus 7 patients in group B and 6 patients in group C (24%). In
all patients itching was of mild intensity except that one patient
500 A. Hassanein et al.in group A was of moderate intensity; however, none of them
was disturbed or required any treatment and P-value was 0.63
with mild itching and 0.36 with moderate itching. Incidence of
urinary retention in group A was occurred in 7 patients versus
6 patients in group B and 4 patients in group C and also P-
value was 0.58; all patients developed retention treated by
insertion of urinary catheter for 24 h and then catheter was
removed without any residual complaint.
5. Discussion
In our study 75 male and female patients aged from 18 to
65 years from ASA class I or II undergoing lumbar laminec-
tomy under general anesthesia randomly were divided into
three equal groups 25 in each group. Anesthetic technique
was standardized in all the groups and at the completion of
laminectomy group A 5 mg morphine (1 mg/ml) was instilled
over the intact epidural space whereas in group B apiece of gel-
foam 5 cm  1 cm soaked in 5 mg morphine diluted with 5 ml
crystalloid (sodium chloride 0.9%) placed in intact epidural
space and in group C apiece of gelfoam 5 cm  1 cm soaked
in 5 mg morphine diluted with 5 ml colloid (HES 6%) placed
in intact epidural space, and we found that epidural adminis-
tration of morphine using gelfoam is an effective method for
post operative analgesia after lumbar laminectomy; in addi-
tion, soaking of gelfoam in HES 6% resulted in longer dura-
tion of analgesia, lesser analgesic consumption postoperative
with minimal side effects, as we observed that the mean VAS
score in the group C remained less as compared to group B
and group A at most times of study. This implies that patients
in group C had less pain as compared to other two groups, and
total analgesic consumption was greater in group A than in
gelfoam groups and time to first analgesic request was longer
in groups B and C than in group A, with earlier ambulation
in gelfoam groups in than group A. The explanation of earlier
ambulation in both groups in which gelfoam soaked morphine
was used makes most patients pain-free and this is important
because earlier ambulation lifts the morale of the patient,
relieves the surgeon’s anxiety and also reduces the chances of
postoperative complications. While better control of pain in
groups B and C and rapid fading painkilling effect of mor-
phine in group A because of free opiates placed at the time
of the surgery are diluted by blood and tissue fluids, they are
lost into the disk space, and are absorbed systemically, thus
limiting its duration of action [14]. Morphine was the first opi-
oid approved by the Foods and Drugs Administration (FDA)
for spinal administration and it is the epidural opioids that
have been the most widely used and with which others are
compared [4]. After spine surgery epidural catheters are diffi-
cult to manage and maintain. In addition, there is always a
concern of infection, restricting its widespread application
[3]. Other investigators have attempted to prolong the duration
of analgesic action by morphine-adon L compound, Oxiplex/
SP gel-morphine [10] and Vaseline-Sterile-Oil-Morphine [11]
and many of these techniques lack wider applicability. Liposo-
mal based extended release epidural morphine (EREM) has
been recently introduced and successfully used extending the
duration of analgesic action of morphine. However, this prepa-
ration is costly and not easily available [12]. The easy access to
epidural space during laminectomy surgery can be utilized for
applying morphine directly over the exposed dura mater andthe routine use of surgical gelfoam in the epidural space at
the completion of surgery encouraging us to use gelfoam as
an extended release drug delivery system in our study. Earlier
studies have tried application of gelfoam soaked in saline with
opiates in epidural space. Mishra et al. tried 0.3 mg buprenor-
phine diluted to 5 ml with normal saline soaked into an
absorbable gelatin sponge was placed in the epidural space
under direct vision as a technique for extended ambulatory
epidural pain control after lumbar discectomy [5]. Another
study by Gibsons, et al. tried another technique in which an
absorbable gelatin sponge (Gelfoam) is contoured to the
laminectomy defect, placed in methylprednisolone acetate
(40–80 mg), and then injected with 2–4 mg of preservative-
free morphine (a small needle was used to fill the sponge).
The sponge is placed over the defect before closure [13]. While
Kundra et al. compared the effect gelfoam soaked in morphine
to direct epidural application of morphine [6] but in these stud-
ies morphine was diluted by saline, efficacy and duration of
action of morphine when diluted with colloid like hydrox-
yethyl starches (HES 6%) were not compared when applicated
via gelfoam to other methods mentioned before, so no defini-
tive conclusions can show the differences between each of col-
loids and crystalloids with gelfoam soaked morphine
compared to direct morphine application. When we compare
our study with other studies we find that the dose of epidural
morphine used in our study corresponds to the doses used in
earlier studies. Gibson Kevin used single dose of 4 mg in lum-
bar spine surgery [13]. Chen used 3 mg epidural morphine in
lumbar laminectomy surgery [15], Carvalho et al. used 5 mg
epidural morphine in obstetric patient [16], and gambling used
5 mg morphine in epidural space for lower abdominal surgeries
[17]. Some authors have tried using even smaller doses of
epidural morphine in an attempt to reduce the incidence and
severity of adverse effects. Wu et al., used 1 mg doses of mor-
phine using a microfibrillary paste; however, using such smal-
ler doses also reduces duration of analgesic effect [14]. Study
done by Kundra et al. was in agreement with our study that
compares gelfoam soaked morphine with crystalloid. This
was in conformity with our work in group B and group A
respectively, and they reported that mean VAS score in group
1 (gelfoam morphine) remained less as compared to group 2
(direct epidural morphine) at most time intervals studied. This
implies that patients in group 1 had less pain as compared to
group 2. The mean duration of action of a single dose epidural
instillation of morphine was 10.25 h in group 2 and it pro-
longed to 30.25 h in group 1. In group 2, total analgesic con-
sumption was almost greater than 3.5 times and
supplemental analgesia was required almost 20 h earlier as
compared to group 1, with short time to ambulation and
higher sedation scores in gelfoam group. Carvalho et al.
reported the single dose of epidural morphine to provide anal-
gesia for 3 h and this difference could be due to the fact that
the study was performed in post-cesarean patients, and preg-
nant state is known to alter pain perception [16]. Yaddanapudi
et al., reported that the effect of single dose of epidural mor-
phine lasted 10.1 h and this was in agreement with our result
in group A and we have clear prolongation in gelfoam groups
bearing in mind that this study compares epidural morphine
by conventional method to epidural tramadol [18]. Gibson
et al., reported that 60% of patients did not require supple-
mental analgesia on the day of surgery when gelfoam soaked
Colloid versus crystalloid soaked gelfoam 501in morphine was placed in the epidural space [13]. However, in
that study, dose of morphine injected in the gelfoam was not
standardized (2–4 mg) and methylprednisolone was also
injected in the gelfoam. Although there was statistically signif-
icant reduction in values of MAP and HR and RR in varying
degrees when compared with their base line values, there was
no clinically symptomatic hypotension, bradycardia or respira-
tory depression required any treatment with naloxone or sup-
plemental oxygen. The incidence of other adverse effects in our
study was small with insignificant differences in incidences of
postoperative nausea and vomiting (PONV), itching and uri-
nary retention between the studied groups. Kundra et al.
reported that incidence of postoperative nausea only when in
group 1 was 26.7% vs. 33.3% in group 2 while incidence of
vomiting was 8% vs. 13.33% respectively whereas incidence
of itching was 30.66% within group 1 vs. 38.66% in group 2
and incidence of urinary retention was 8% in group 1 vs.
0% in group 2 [6]. In comparison with our study the incidence
of PONV and itching was convergent but our study still has
lower incidences clearly noticed in group C; this can be
explained by smaller doses of morphine released from gelfoam
soaked in colloid. As regards urinary retention higher inci-
dences were observed in our study in all groups. We cannot
explain this as clearly as there was no clear explanation for
the lack of retention with directly applicated morphine in the
study done by Kundra et al. There are many theories that
explain the effect of epidural opioids in general on the urody-
namic function. In a nationwide follow-up survey in Sweden,
anesthesiologists reported a greater incidence of postoperative
urinary retention (POUR) with epidural morphine (38%) com-
pared with intrathecal morphine (13%) [19]. However, at close
analysis, the patients who developed POUR had bladder
catheterization as a result of the type and the duration of sur-
gery, making assessment of POUR more difficult. The inci-
dence of POUR after epidural opioids may also be related to
the level at which opioids are injected. Administration of opi-
oids in the lumbar epidural space is associated with higher rate
of urinary retention compared to thoracic [20]. Detrusor
strength starts to decrease within 5–15 min after 4 mg of epidu-
ral morphine, and its maximum effect reached between 30 and
120 min and lasting 10–15 h [19]. Left to point out, there were
several limitations to the current study and further studies are
needed to compare the effect of different doses of morphine
aiming to detect the optimal dose that provides longer dura-
tion of analgesia with least side effects.
In conclusion, epidural administration of morphine using
gelfoam is an effective method for post operative analgesia
after lumbar laminectomy using gelfoam soaked in HES 6%
resulted in longer duration of analgesia and lesser postopera-
tive analgesic consumption with minimal side effect.
5.1. Recommendation
We recommend routine use of epidural gelfoam soaked mor-
phine with colloid in our hospital, but we encourage further
studies that conducted blindly and involving larger sample size
of population of different ASA classifications and try different
doses of morphine aiming to detect the optimal dose that pro-
vides longer duration of analgesia with least side effects. Also,
we can try other adjuvant to improve the quality of analgesic
effect of morphine in gelfoam carrier as using steroids suchas methylprednisolone that can reduce postoperative radicu-
lopathy due to its anti-inflammatory effect that reduces inflam-
mation around nerve root and also reduces usage of systemic
steroids post operative. It remains to point out that we did
not have long term follow-up of patients to evaluate chronic
post-surgical pain (CPSP) and it was a weak point in current
study as occurrence of CPSP may be one of pressure symptoms
due to epidural gelfoam. This is extremely important because
compression of nerve roots can cause motor or sensory deficits
in the area of distribution.
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